openPR Logo
Press release

Oncology Information System Market by leading players Bogardus Medical Systems, Inc., Cerner Corporation, CureMD Corporation, Elekta AB, Flatiron Health, Inc., Koninklijke Philips N.V., McKesson Corporation, RaySearch Laboratories AB, and Varian Medical S

09-17-2018 10:42 AM CET | Health & Medicine

Press release from: Allied Market Research

Oncology Information System Market- AMR

Oncology Information System Market- AMR

Oncology Information System Market Report, published by Allied Market Research, forecasts that the global market was valued at $2,247 million in 2015 and is expected to garner $3,755 million by 2022, registering a CAGR of 7.5% during the forecast period 2016 - 2022. North America is the highest contributor in the oncology information systems market; however, Asia-Pacific is witnessing the highest growth rate.

The report provides extensive competitive analysis and profiles of key market players such as Accuray Incorporated, Bogardus Medical Systems, Inc., Cerner Corporation, CureMD Corporation, Elekta AB, Flatiron Health, Inc., Koninklijke Philips N.V., McKesson Corporation, RaySearch Laboratories AB, and Varian Medical Systems, Inc.

Get sample PDF copy @ https://www.alliedmarketresearch.com/request-sample/790

Other players in the value chain include IMPAC Medical Systems, Inc., Siemens Healthcare, Epic Systems Corporation, Bizmatics, Inc., Charm Health, and Cordata Healthcare Innovations, LLC.

Oncology information systems enable management of patient profiles by combining surgical, radiation, and medical oncology information in one system. Moreover, these systems facilitate management of treatment plans and schedules of cancer patients, and predict the results of the treatments. Safety and efficiency of cancer treatment is improved by use of these systems owing to their ability to predict the treatment outcome.

The benefits of implementing oncology information systems over conventional methods of record keeping and treatment planning are expected to boost the growth of the oncology information systems market. The advantages of oncology information systems such as planned treatment, future-proofing, and remote access are expected to increase the demand for these systems and motivate the government organizations to upgrade their procedure from paper-based systems to paperless systems. Furthermore, the increase in disposable income among cancer patients, surge in prevalence of cancer cases, and technological advancements in these systems, such as incorporation of patient portals, are anticipated to fuel the market growth. Rise in healthcare expenditure in developing countries, such as India and China, advancement in software using artificial intelligence, and use of oncology information systems to treat rare cancers are expected to present multiple opportunities for market growth. However, this growth is restricted owing to lack of healthcare IT professionals and high capital costs associated with oncology information systems.

Among the product & service segment, software for patient information system was the largest revenue contributor in 2015 towards market growth, and is anticipated to continue this trend in the future. Advantages of using these systems as compared to conventional record maintenance methods such as planned treatment and remote access due to digital availability are expected to boost the growth of this segment.

Medical oncology dominates the oncology information systems market. In medical oncology, oncology information systems software manages, interprets, analyzes, and stores the patient information efficiently. In addition, as the software assists to predict the treatment outcome for patients, it helps to improve the survival rate of the patient and drives the oncology information systems market growth.

Do purchase inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/790

In 2015, North America accounted for maximum contribution to the total revenue generated, owing to the high prevalence rate of cancer and high adoption rate of technologically advanced products. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to rise in disposable income, increase in government initiatives to modernize healthcare infrastructure, and rise in healthcare expenditure.

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology Information System Market by leading players Bogardus Medical Systems, Inc., Cerner Corporation, CureMD Corporation, Elekta AB, Flatiron Health, Inc., Koninklijke Philips N.V., McKesson Corporation, RaySearch Laboratories AB, and Varian Medical S here

News-ID: 1241690 • Views:

More Releases from Allied Market Research

The Future of Eco-Friendly Commuting : Electric Bike Kits Set to Reach $2,902.4 Million by 2032
The Future of Eco-Friendly Commuting : Electric Bike Kits Set to Reach $2,902.4 …
Allied Market Research published a report, titled, "Electric Bike Kit Market by Usage, (Mountain Bicycle, Road Bicycle, Cargo Bicycle and Others), Battery (Lithium-Ion, Lead Acid, and Others), and Speed, (Up to 25 kmph, 25-45 kmph, and Above 45 kmph): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global electric bike kit industry size generated $1,095.3 million in 2022 and is estimated to reach $2,902.4 million by
Global Passenger Car Accessories Aftermarket Accelerates Towards $248.41 Billion by 2026
Global Passenger Car Accessories Aftermarket Accelerates Towards $248.41 Billion …
As per the report published by Allied Market Research, the global passenger car accessories aftermarket was pegged at $128.97 billion in 2018, and is expected to reach $248.41 billion by 2026, growing at a CAGR of 8.5% from 2019 to 2026. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 - https://www.alliedmarketresearch.com/request-sample/A06108 Stringent government regulations to upgrade the accessories, increase in the trend of vehicle customization, rise in disposable income, and high focus on well-being of drivers have
V2X Cybersecurity Market Projected to Hit $5.7 Billion by 2031 | Allied Market Research
V2X Cybersecurity Market Projected to Hit $5.7 Billion by 2031 | Allied Market R …
Allied Market Research recently published a report, "V2X Cybersecurity Market by Unit Type (On-Board Unit, Roadside Unit), by Vehicle Type (Passenger Car, Light Commercial Vehicle, Heavy Commercial Vehicle), by Propulsion Type (ICE, Electric and Hybrid, Others), by Communication (Vehicle-To-Vehicle, Vehicle-To-Infrastructure, Vehicle-To-Grid, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031". According to the report, the global V2X Cybersecurity market size is predicted to garner a revenue of $5.7 billion by 2031.
Phenolic Resin in North America and Europe Market to Surge at CAGR of 4.7% over 2024-2031
Phenolic Resin in North America and Europe Market to Surge at CAGR of 4.7% over …
According to the report published by Allied Market Research, the North America and Europe phenolic resin market was estimated at $4.4 billion in 2021 and is expected to hit $7.0 billion by 2031, registering a CAGR of 4.7% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The

All 5 Releases


More Releases for Oncology

Immuno Oncology Assays Market Size, Immuno Oncology Assays Market Prediction, Im …
The Immuno Oncology Assays Market Report examines the Immuno Oncology Assays industry from a variety of angles, including market size, status, trends, and forecasts. It also gives a quick rundown of the top competitors and development opportunities in the market. The research contains a comprehensive study of the keyword market, split by companies, regions, types, and applications. The research goes into great detail on several aspects that have been studied as
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipated